175 related articles for article (PubMed ID: 15760870)
1. Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T.
Wellard RM; Briellmann RS; Jennings C; Jackson GD
AJNR Am J Neuroradiol; 2005 Mar; 26(3):585-90. PubMed ID: 15760870
[TBL] [Abstract][Full Text] [Related]
2. Validation of in vivo MRS measures of metabolite concentrations in the human brain.
Dhamala E; Abdelkefi I; Nguyen M; Hennessy TJ; Nadeau H; Near J
NMR Biomed; 2019 Mar; 32(3):e4058. PubMed ID: 30663818
[TBL] [Abstract][Full Text] [Related]
3. MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation.
Feldmann J; Martin P; Bender B; Laugwitz L; Zizmare L; Trautwein C; Krägeloh-Mann I; Klose U; Groeschel S
Neuroimage Clin; 2023; 37():103296. PubMed ID: 36563646
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility and reliability of short-TE whole-brain MR spectroscopic imaging of human brain at 3T.
Ding XQ; Maudsley AA; Sabati M; Sheriff S; Dellani PR; Lanfermann H
Magn Reson Med; 2015 Mar; 73(3):921-8. PubMed ID: 24677384
[TBL] [Abstract][Full Text] [Related]
5. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome.
Śmigielska-Kuzia J; Boćkowski L; Sobaniec W; Kułak W; Sendrowski K
Pharmacol Rep; 2010; 62(6):1070-7. PubMed ID: 21273664
[TBL] [Abstract][Full Text] [Related]
6. A multicenter reproducibility study of single-voxel 1H-MRS of the medial temporal lobe.
Träber F; Block W; Freymann N; Gür O; Kucinski T; Hammen T; Ende G; Pilatus U; Hampel H; Schild HH; Heun R; Jessen F
Eur Radiol; 2006 May; 16(5):1096-103. PubMed ID: 16416279
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
Tong ZY; Toshiaki Y; Wang YJ
Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
[TBL] [Abstract][Full Text] [Related]
8. Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy.
Simister RJ; McLean MA; Barker GJ; Duncan JS
Neurology; 2003 Oct; 61(7):897-902. PubMed ID: 14557556
[TBL] [Abstract][Full Text] [Related]
9. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
10. Quantitative 1H MRS of the human brain in vivo based on the stimulation phantom calibration strategy.
Duc CO; Weber OM; Trabesinger AH; Meier D; Boesiger P
Magn Reson Med; 1998 Mar; 39(3):491-6. PubMed ID: 9498606
[TBL] [Abstract][Full Text] [Related]
11. Intralipid/Heparin Infusion Alters Brain Metabolites Assessed With 1H-MRS Spectroscopy in Young Healthy Men.
Karczewska-Kupczewska M; Nikolajuk A; Filarski R; Majewski R; Tarasów E
J Clin Endocrinol Metab; 2018 Jul; 103(7):2563-2570. PubMed ID: 29860500
[TBL] [Abstract][Full Text] [Related]
12. Age-related change in brain metabolite abnormalities in autism: a meta-analysis of proton magnetic resonance spectroscopy studies.
Aoki Y; Kasai K; Yamasue H
Transl Psychiatry; 2012 Jan; 2(1):e69. PubMed ID: 22832731
[TBL] [Abstract][Full Text] [Related]
13. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy.
Ernst T; Chang L; Melchor R; Mehringer CM
Radiology; 1997 Jun; 203(3):829-36. PubMed ID: 9169712
[TBL] [Abstract][Full Text] [Related]
14. In vivo detection of postictal perturbations of cerebral metabolism by use of proton MR spectroscopy: preliminary results in a canine model of prolonged generalized seizures.
Neppl R; Nguyen CM; Bowen W; Al-Saadi T; Pallagi J; Morris G; Mueller W; Johnson R; Prost R; Rand SD
AJNR Am J Neuroradiol; 2001; 22(10):1933-43. PubMed ID: 11733328
[TBL] [Abstract][Full Text] [Related]
15. The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study.
Burger A; Brooks SJ; Stein DJ; Howells FM
Drug Alcohol Depend; 2018 Apr; 185():226-237. PubMed ID: 29471227
[TBL] [Abstract][Full Text] [Related]
16. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
Zhu X; Schuff N; Kornak J; Soher B; Yaffe K; Kramer JH; Ezekiel F; Miller BL; Jagust WJ; Weiner MW
Alzheimer Dis Assoc Disord; 2006; 20(2):77-85. PubMed ID: 16772742
[TBL] [Abstract][Full Text] [Related]
17. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
[TBL] [Abstract][Full Text] [Related]
18. Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy.
Wattjes MP; Harzheim M; Lutterbey GG; Klotz L; Schild HH; Träber F
AJNR Am J Neuroradiol; 2007 Sep; 28(8):1517-22. PubMed ID: 17846203
[TBL] [Abstract][Full Text] [Related]
19. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
[TBL] [Abstract][Full Text] [Related]
20. In vivo quantitation of cerebral metabolite concentrations using natural abundance 13C MRS at 1.5 T.
Blüml S
J Magn Reson; 1999 Feb; 136(2):219-25. PubMed ID: 9986765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
